Fig. 1From: An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab eraOverall survival (OS) of patients based on inflammation-based cumulative prognostic score (ICPS) system. The ICPS system classified patients into four OS risk groups (ICPS = 0, ICPS = 1, ICPS = 2 and ICPS = 3)Back to article page